TABLE 2.
Serogroup | 2001-2002 |
2005-2006 |
% Changea | ||||
---|---|---|---|---|---|---|---|
No. (%) of cases | No. of cases/105 persons | % of IPD incidence | No. of cases | No. of cases/105 persons | % of IPD incidence | ||
4 | 35 | 0.69 | 6.12 | 50 | 0.98 | 7.62 | 1.50 |
6 | 41 | 0.81 | 7.17 | 51 | 1 | 7.77 | 0.60 |
9 | 48 | 0.95 | 8.39 | 51 | 1 | 7.77 | −0.62 |
14 | 121 | 2.39 | 21.15 | 97 | 1.9 | 14.79 | −6.36* |
18 | 19 | 0.38 | 3.32 | 23 | 0.45 | 3.51 | 0.19 |
19 | 52 | 1.03 | 9.09 | 41 | 0.8 | 6.25 | −2.84 |
23 | 47 | 0.93 | 8.22 | 38 | 0.75 | 5.79 | −2.43 |
1 | 20 | 0.39 | 3.50 | 105 | 2.06 | 16.01 | 12.51** |
7 | 24 | 0.47 | 4.20 | 26 | 0.51 | 3.96 | −0.24 |
3 | 30 | 0.59 | 5.24 | 37 | 0.73 | 5.64 | 0.40 |
8 | 33 | 0.65 | 5.77 | 35 | 0.69 | 5.34 | −0.43 |
11 | 14 | 0.28 | 2.45 | 10 | 0.2 | 1.52 | −0.93 |
12 | 20 | 0.39 | 3.50 | 25 | 0.49 | 3.81 | 0.31 |
22 | 21 | 0.41 | 3.67 | 12 | 0.24 | 1.83 | −1.84 |
**, P < 0.0001; *, P < 0.005.